Myovant Sciences - Stock Price History | MYOV
Historical daily share price chart and data for Myovant Sciences since 2022 adjusted for splits. The latest closing stock price for Myovant Sciences as of August 15, 2022 is 18.40.
- The all-time high Myovant Sciences stock closing price was 27.62 on December 31, 2020.
- The Myovant Sciences 52-week high stock price is 27.43, which is 49.1% above the current share price.
- The Myovant Sciences 52-week low stock price is 7.67, which is 58.3% below the current share price.
- The average Myovant Sciences stock price for the last 52 weeks is 15.55.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Myovant Sciences Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2021 |
21.1945 |
24.8300 |
26.9900 |
14.3100 |
15.5700 |
-43.63% |
| 2020 |
15.7647 |
14.7600 |
27.6200 |
6.5500 |
27.6200 |
77.96% |
| 2019 |
13.1238 |
16.9300 |
25.0000 |
4.2000 |
15.5200 |
-5.42% |
| 2018 |
19.8959 |
12.4600 |
26.7800 |
12.4600 |
16.4100 |
29.83% |
| 2017 |
12.3598 |
11.8400 |
16.4000 |
9.9300 |
12.6400 |
1.61% |
| 2016 |
11.5871 |
13.2600 |
14.2500 |
10.4500 |
12.4400 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.774B |
$0.231B |
|
Myovant Sciences Ltd. is a biopharmaceutical company. It focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders, including advanced prostate cancer. The company's product candidate consists of relugolix which are in clinical trial, an oral once-daily small molecule that acts as a gonadotropin-releasing hormone receptor antagonist. Myovant Sciences Ltd. is based in Hamilton, Bermuda.
|
